267 related articles for article (PubMed ID: 12877022)
1. [The treatment of OCD].
Sumitani S; Ohmori T
Ryoikibetsu Shokogun Shirizu; 2003; (38):442-5. PubMed ID: 12877022
[No Abstract] [Full Text] [Related]
2. A case of social phobia with obsessive-compulsive symptoms improved by paroxetine in combination with risperidone.
Yamauchi K; Ohta K; Taniguchi T; Ohmori T
Gen Hosp Psychiatry; 2004; 26(3):242-3. PubMed ID: 15121355
[No Abstract] [Full Text] [Related]
3. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
Pigott TA; Seay SM
J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels.
Yoshimura R; Kaneko S; Shinkai K; Nakamura J
Psychiatry Clin Neurosci; 2006 Jun; 60(3):389-93. PubMed ID: 16732759
[TBL] [Abstract][Full Text] [Related]
5. Management of treatment-refractory obsessive compulsive disorder patients.
Dominguez RA; Mestre SM
J Clin Psychiatry; 1994 Oct; 55 Suppl():86-92. PubMed ID: 7961537
[TBL] [Abstract][Full Text] [Related]
6. A case report of risperidone-induced obsessive-compulsive symptoms.
Alzaid K; Jones BD
J Clin Psychopharmacol; 1997 Feb; 17(1):58-9. PubMed ID: 9004062
[No Abstract] [Full Text] [Related]
7. Alcohol binge drinking in OCD: A compulsive ritualistic behaviour to counter magical thinking.
Dwivedi S; Kar SK
Asian J Psychiatr; 2017 Oct; 29():160-161. PubMed ID: 29061418
[No Abstract] [Full Text] [Related]
8. Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy.
Alonso P; Menchon JM; Pifarre J; Mataix-Cols D; Torres L; Salgado P; Vallejo J
J Clin Psychiatry; 2001 Jul; 62(7):535-40. PubMed ID: 11488364
[TBL] [Abstract][Full Text] [Related]
9. Augmentation with cognitive behavioural therapy has superior efficacy to augmentation with risperidone for treating adults with treatment-resistant OCD.
O'Neill J
Evid Based Ment Health; 2014 May; 17(2):58-9. PubMed ID: 24713316
[No Abstract] [Full Text] [Related]
10. [The mental disorder and obsessive-compulsive spectrum disorders in childhood ].
Okada T
Seishin Shinkeigaku Zasshi; 2011; 113(10):992-8. PubMed ID: 22292193
[No Abstract] [Full Text] [Related]
11. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
[TBL] [Abstract][Full Text] [Related]
12. Clinical predictors of drug response in obsessive-compulsive disorder.
Erzegovesi S; Cavallini MC; Cavedini P; Diaferia G; Locatelli M; Bellodi L
J Clin Psychopharmacol; 2001 Oct; 21(5):488-92. PubMed ID: 11593074
[TBL] [Abstract][Full Text] [Related]
13. Drug treatment of obsessive-compulsive disorder.
Lelliott PT; Monteiro WO
Drugs; 1986 Jan; 31(1):75-80. PubMed ID: 2866948
[TBL] [Abstract][Full Text] [Related]
14. Outcome of additional behaviour therapy including treatment discontinuation for fluvoxamine non-responders with obsessive-compulsive disorder.
Nakatani E; Nakagawa A
Psychother Psychosom; 2008; 77(6):393-4. PubMed ID: 18716426
[No Abstract] [Full Text] [Related]
15. Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders.
Denys D
Psychiatr Clin North Am; 2006 Jun; 29(2):553-84, xi. PubMed ID: 16650723
[TBL] [Abstract][Full Text] [Related]
16. [Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders].
Nakamae T
Seishin Shinkeigaku Zasshi; 2011; 113(10):1016-25. PubMed ID: 22187889
[TBL] [Abstract][Full Text] [Related]
17. Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases.
McDougle CJ; Fleischmann RL; Epperson CN; Wasylink S; Leckman JF; Price LH
J Clin Psychiatry; 1995 Nov; 56(11):526-8. PubMed ID: 7592506
[TBL] [Abstract][Full Text] [Related]
18. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators.
Zohar J; Judge R
Br J Psychiatry; 1996 Oct; 169(4):468-74. PubMed ID: 8894198
[TBL] [Abstract][Full Text] [Related]
19. Serotonin reuptake inhibitor treatment of obsessive-compulsive symptoms in clozapine-medicated schizophrenia.
Andrade C
J Clin Psychiatry; 2012 Nov; 73(11):e1362-4. PubMed ID: 23218164
[No Abstract] [Full Text] [Related]
20. Augmenting obsessive-compulsive disorder treatment: from brain to mind.
Ressler KJ; Rothbaum BO
JAMA Psychiatry; 2013 Nov; 70(11):1129-31. PubMed ID: 24026506
[No Abstract] [Full Text] [Related]
[Next] [New Search]
